Gearing up Biosimilar Development with Innovation and Integration

  • Asia’s leading and most highly-anticipated event
  •  Highlights on market access and commercialization case study
  •   The region’s largest gathering of leading and future stakeholders across the value chain
Special Group Savings Available!
Register a team of 3 or more delegates, and the 4th delegate attends for FREE!

Biosimilars are a clear potential for players in emerging Asian countries, as India, Taiwan, and China are displaying strong potential to emerge as prominent players. The increasing pressure to decrease medical expenses and patent expiry of original biopharmaceutical has fueled biosimilar product development in Asian countries.   

Join Biosimilar China to explore practical strategies for gaining access to emerging markets, managing the role of innovator companies, commercializing biosimilars and siting successful case studies. The event will also drill into the opportunities and challenges in clinical trials including implications for clinical development and latest insights into developing an efficient scale up process.

KEY THEMES

  • Establishing R&D Capabilities in China
  • Biosimilars Investments, Emerging Markets & Market Access Strategies
  • Biobetters vs. Biosimilars: Which Way to Go?
  • Establishing Similarity – What Level of Similarity is Acceptable?
  • Improving Characterisation of Biosimilars with Technology
  • Scaling Up & Improving Biosimilar Process Capabilities

 

About the Biopharma Development & Production Week

The Biopharma Development & Production Week is the leading industry platform for pharma, biotech, CMOs, CROs, research institutes, investors and industry stakeholders to meet, network and discuss current industry trends, establish business partnerships and be updated on investment opportunities in China and surrounding Asia.  For more information visit www.biopharmaproduction.com

3 Conferences in 1 Location

 

Unrivalled Speakers Lineup Includes

Jean-Christophe Pointeau
General Manager, Pharma China
Sanofi
Dr. Raymond De Vré
Vice President Biologics
Dr. Reddy's Laboratories SA
Martina Sersch
Senior Medical Director, Oncology Global Development, APAC Biologics Strategy Lead
Jinming Gu
Executive Director
Shanghai Hengrui Pharmaceutical Co Ltd
Shou-Bai Chao
SVP of Bio Venture - Global Operations
AstraZeneca   
Grant Shoebridge
Principal
Shelston IP
George Wang
Founder and CEO
Mab-Venture Co. Ltd
 

View all speakers »

 

 

Produced bySupporting Association

Gold SponsorBronze Sponsors 
Exhibitors  
  
Media Partners  
IBC

International Marketing Partner